X39 Patch study: effects on certain copper peptides in healthy adults
This study tests whether wearing the X39 patch (a small adhesive patch) changes levels of certain natural copper peptides in your blood. It might help understand how the patch works in healthy adults 35 and older.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 35 years or older
- You must be in good general health
- If you are a woman who could become pregnant, you must use an approved birth control method for the whole study
- You agree to avoid hard exercise, alcohol, and NSAIDs (like ibuprofen) for 24 hours before each study visit
- You agree to keep your usual diet, activity, and sleep habits throughout the study
- You must not have certain medical conditions like diabetes, liver or kidney disease, or a history of cancer (except minor skin cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a copper-peptide gel applied to a small, fresh wound to see if it helps healing. It is meant for healthy adults aged 18 to 55 who are not smokers and have no skin problems or conditions that slow healing.
This Phase 2 study tests how well a testosterone skin treatment (testosterone delivered through the skin) works in healthy adults. It also checks how your body absorbs and handles the medicine, using repeated blood draws and on-site visits.
This study looks at how the body handles a medication called HLX29 compared to a similar one called HLX11 in healthy men. It helps find the right dose and check for side effects.
This trial tests a new contraceptive patch to see if it can prevent ovulation (the release of an egg). If you are a healthy woman looking for a non-hormonal birth control option, this study may be a good fit.
This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.
This Phase 2 trial tests different doses of a testosterone skin patch to see which works best and is absorbed safely. It may help men with low morning testosterone who can meet study requirements like non-smoking and multiple blood draws.
Hear when a new GHK and GHK-Cu Blood Levels trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.